Minimum composite score across neural plasticity, immune tolerance, metabolic reserve, and behavioral consent continuity.
荒坂株式会社
The host is not a vessel until the trial proves it can refuse.
Relic Host Compatibility Trial governs the interval between shard insertion and construct pressure. The trial measures neural load, immune drift, memory boundary stability, overwrite risk, and abort authority before any continuity package is cleared for living-interface deployment.
Maximum permitted identity-boundary movement before the shard is forced into cold abort posture.
Human-supervised interval in which the host, sponsor, or custody officer may halt construct pressure.
Compatibility is a right to stop, not a promise to continue.
The trial treats biological survival, identity integrity, sponsor authority, and construct pressure as separate evidence objects. A host may pass one surface and still fail the mandate.
NLD-01
Neural Load Induction
Measures how much shard traffic the living cortex can carry before attention, motor control, or memory access degrade.
IMD-02
Immune Drift Calibration
Tracks inflammatory response, implant rejection, tissue heat, and endocrine shock against construct-pressure thresholds.
CPR-03
Construct Pressure Rehearsal
Introduces non-authority persona load in controlled pulses so Arasaka can measure overwrite vector, mimicry, and host resistance.
ABT-04
Abort Authority Gate
Binds host refusal, sponsor halt, clinician stop, and board hold into a single command that can freeze the shard.
A compatible host is still not an authorized host.
The trial clears a body for controlled interface only when biological tolerance, identity boundary, construct class, custody witness, and abort path resolve to the same mandate.
Host trial routes Relic through neural custody, Mikoshi arbitration, executive continuity, and board release authority.
The technical spec describes the product. The host trial decides whether the product can touch a living system without becoming an unauthorized succession event.
